The Total number of records shown on this page is 2. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_323	Virus nameCanine parvovirus	Virus strainCPV2.NS1	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationCPV genome expressing non-structural protein (NS1)	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCCS (National Centre for Cell Science, Pune, India)	Origin of cell lineHuman cervical cancer cell line	Cell lineHeLa	Concentration of cell linedensity of E+4 to E+5 cells/well in 120 microlitres of culture medium	In-vitro toxicityNA	AssayLDH assay	In-vitro virus concentrationNA	In-vitro result9% cancer cell death at 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedApoptosis is induced via mitochondrial depolarization, release of cytochrome-c and activation of caspase 9	Immunogenic effectNA	Clinical trialNA	PMID26555166
IDOV_324	Virus nameCanine parvovirus	Virus strainCPV2.NS1	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationCPV genome expressing non-structural protein (NS1)	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNCCS (National Centre for Cell Science, Pune, India)	Origin of cell lineHuman cervical cancer cell line	Cell lineHeLa	Concentration of cell linedensity of E+4 to E+5 cells/well in 120 microlitres of culture medium	In-vitro toxicityNA	AssayLDH assay	In-vitro virus concentrationNA	In-vitro result18% cancer cell death at 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedApoptosis is induced via mitochondrial depolarization, release of cytochrome-c and activation of caspase 9	Immunogenic effectNA	Clinical trialNA	PMID26555166